Robert Davis, Merck CEO
Merck shares slide as response to its oral Covid antiviral plunges on latest update ahead of adcomm
After a second look, Merck says that its big breakthrough on the Covid front doesn’t look so good. An FDA adcomm of outside experts will …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
